FOCAL ONSET SEIZURES
Clinical trials for FOCAL ONSET SEIZURES explained in plain language.
Never miss a new study
Get alerted when new FOCAL ONSET SEIZURES trials appear
Sign up with your email to follow new studies for FOCAL ONSET SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New epilepsy drug SPN-817 tested for Long-Term safety in adults
Disease control Recruiting nowThis study looks at the long-term safety and effectiveness of an investigational drug called SPN-817 for adults with focal onset seizures. About 100 people who completed a previous SPN-817 study will take the drug for one year. Researchers will track side effects and changes in s…
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 07:50 UTC
-
New hope for seizure control: phase 3 trial launches
Disease control Recruiting nowThis study tests an experimental drug called XEN1101 for people with focal-onset seizures (a type of epilepsy). About 360 adults will receive either the drug or a placebo alongside their current seizure medications. The goal is to see if XEN1101 safely reduces seizure frequency b…
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC